Coldstream Capital Management Inc Pfizer Inc Transaction History

Coldstream Capital Management Inc

$4.58 Billion
Q3 2024

A detailed history of Coldstream Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 108,212 shares of PFE stock, worth $2.89 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

108,212

Previous 94,677 14.3%

Holding current value

$2.89 Million

Previous $2.65 Million 18.2%

% of portfolio

0.07%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$27.7 - $31.39 $374,919 - $424,863	13,535 Added 14.3%	108,212 $3.13 Million
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $424,115 - $496,984	16,790 Added 21.56%	94,677 $2.65 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $176,388 - $202,550	6,813 Added 9.59%	77,887 $2.16 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $2.28 Million - $2.96 Million	-87,136 Reduced 55.08%	71,074 $2.05 Million
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $160,193 - $187,249	-4,992 Reduced 3.06%	158,210 $5.25 Million
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $46,414 - $53,700	1,285 Added 0.79%	163,202 $5.99 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $202,779 - $263,989	-5,148 Reduced 3.08%	161,917 $6.61 Million
Q4 2022 Jan 10, 2023	SELL	$41.75 - $54.5 $59,159 - $77,226	-1,417 Reduced 0.84%	167,065 $0
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $1.38 Million - $1.64 Million	29,711 Added 21.41%	168,482 $8.83 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $784,309 - $929,945	-16,856 Reduced 10.83%	138,771 $7.28 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $526,445 - $652,331	-11,507 Reduced 6.88%	155,627 $8.06 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $2.19 Million - $3.25 Million	53,109 Added 46.58%	167,134 $9.87 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $782,409 - $1.01 Million	-19,934 Reduced 14.88%	114,025 $4.19 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $78,786 - $89,251	2,194 Added 1.67%	133,959 $5.25 Million
Q1 2021 Jun 16, 2021	BUY	$33.49 - $37.77 $231,081 - $260,613	6,900 Added 5.53%	131,765 $4.77 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $630,373 - $801,575	18,834 Added 17.76%	124,865 $4.6 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $78,263 - $91,821	2,465 Added 2.38%	106,031 $3.89 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $26,776 - $32,484	889 Added 0.87%	103,566 $3.39 Million
Q1 2020 May 27, 2020	BUY	$27.03 - $38.62 $178,560 - $255,123	6,606 Added 6.88%	102,677 $3.35 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $313,760 - $356,078	9,531 Added 11.01%	96,071 $3.76 Million
Q3 2019 Nov 15, 2019	SELL	$32.49 - $42.13 $233,115 - $302,282	-7,175 Reduced 7.66%	86,540 $3.11 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $13,682 - $15,362	370 Added 0.4%	93,715 $4.06 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $566,137 - $621,996	-15,097 Reduced 13.92%	93,345 $3.96 Million
Q4 2018 Feb 26, 2019	BUY	$38.47 - $43.86 $179,693 - $204,870	4,671 Added 4.5%	108,442 $4.73 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $208,991 - $253,494	6,063 Added 6.21%	103,771 $4.57 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $79,316 - $84,559	2,405 Added 2.52%	97,708 $3.55 Million
Q1 2018 May 16, 2018	BUY	$31.91 - $37.02 $124,480 - $144,415	3,901 Added 4.27%	95,303 $3.38 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $133,572 - $141,724	4,016 Added 4.6%	91,402 $3.31 Million
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $150,164 - $165,422	4,844 Added 5.87%	87,386 $3.12 Million
Q2 2017 Aug 15, 2017	BUY	N/A	82,542	82,542 $2.77 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Account

Coldstream Capital Management Inc Pfizer Inc Transaction History